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Edited by Beat ImhofAbstract 2-Arachidonoylglycerol (2-AG), an endogenous can-
nabionoid receptor (CB1 and CB2) ligand, enhanced the adhe-
sion of HL-60 cells diﬀerentiated into macrophage-like cells to
ﬁbronectin and the vascular cell adhesion molecule-1. The CB2
receptor, Gi/Go, intracellular free Ca2+ and phosphatidylinositol
3-kinase were shown to be involved in 2-AG-induced augmented
cell adhesion. 2-AG also enhanced the adhesion of human mono-
cytic leukemia U937 cells and peripheral blood monocytes.
These results strongly suggest that 2-AG plays some essential
role in inﬂammatory reactions and immune responses by induc-
ing robust adhesion to extracellular matrix proteins and adhesion
molecules in several types of inﬂammatory cells and immune-
competent cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: 2-Arachidonoylglycerol; Cannabinoid; Adhesion;
Fibronectin; Macrophage1. Introduction
2-Arachidonoylglycerol (2-AG) is an endogenous ligand for
the cannabinoid receptors (CB1 and CB2). 2-AG exhibits a
variety of cannabimimetic activities in vitro and in vivo [1–
4]. Notably, 2-AG is rapidly produced from membrane phos-
pholipids containing arachidonic acid at the 2-position in
various types of tissues and cells upon stimulation [2–4]. In
fact, the levels of 2-AG in various mammalian tissues are
markedly higher than those of anandamide, another endoge-
nous cannabinoid receptor ligand [2]. Importantly, 2-AG acts
as a full agonist toward the cannabinoid receptors, whereas
anandamide often acts as a partial agonist [2]. These observa-
tions suggested that 2-AG, and not anandamide, is the true
natural ligand for the cannabinoid receptors [2], although this
still remains a controversial issue.Abbreviations: 2-AG, 2-arachidonoylglycerol; DMSO, dimethyl sulf-
oxide; FBS, fetal bovine serum; HBSS, Hanks balanced salt solution;
mAb, monoclonal antibody; MAP kinase, mitogen-activated protein
kinase; PI3K, phosphatidylinositol 3-kinase; PTX, pertussis toxin;
TPA, 12-O-tetradecanoylphorbor 13-acetate; VCAM-1, vascular cell
adhesion molecule-1
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doi:10.1016/j.febslet.2005.10.030Despite its potential physiological signiﬁcance, details of the
physiological functions of 2-AG, especially as a CB2 receptor
agonist, have not yet been fully clariﬁed. In a preceding study,
we found that 2-AG induces the activation of p42/44 mitogen-
activated protein kinase (MAP kinase) in HL-60 cells via a
CB2 receptor-dependent mechanism [5]. We also found that
2-AG induces the migration of HL-60 cells diﬀerentiated into
macrophage-like cells and human peripheral blood monocytes
by acting on the CB2 receptor [6]. Several investigators also re-
ported that 2-AG induces the migration of mouse splenocytes
[7] and microglia cells [8]. Very recently, we found that 2-AG
induces augmented production of chemokines [9] and rapid ac-
tin polymerization [10] in HL-60 cells. Both stimulative and
suppressive eﬀects of 2-AG on lymphocyte proliferation have
also been demonstrated [11,12]. Nevertheless, suﬃcient infor-
mation has not yet been available concerning the roles of
2-AG in inﬂammation and immunity.
In this study, we examined in detail the eﬀect of 2-AG on the
adhesion of HL-60 cells that had been diﬀerentiated into mac-
rophage-like cells. We found that treatment with 2-AG en-
hanced the adhesion of the cells to ﬁbronectin and vascular
cell adhesion molecule-1 (VCAM-1) in a CB2 receptor-depen-
dent manner. Possible physiological and pathophysiological
meanings of the 2-AG-induced enhanced cell adhesion are
discussed.2. Materials and methods
2.1. Chemicals
Arachidonic acid, essentially fatty acid-free bovine serum albumin
(BSA), 1a, 25-dihydroxyvitamin D3 (1a, 25-(OH)2 vitamin D3) and
ﬁbronectin were purchased from Sigma (St. Louis, MO, USA). Re-
combinant human VCAM-1 was obtained from Techne Corp.
(McKinley Place, MN, USA). Wortmannin and herbimycin A were
acquired fromWako Pure Chem. Ind. (Osaka, Japan). 2-AG was ob-
tained from Cayman (Ann Arbor, MI, USA). Y-27632 was pur-
chased from Tocris (Bristol, UK). WIN55212-2 and WIN55212-3
were obtained from RBI (Natick, MA, USA). PD98059 and Ro-31-
8220 were acquired from Calbiochem–Novabiochem (San Diego,
CA, USA). Pertussis toxin (PTX) was purchased from List Biological
Laboratories (Campbell, CA, USA). SR144528 was a generous gift
from Sanoﬁ-Synthelabo Recherche (Montpellier, France). O,O 0-Bis
(2-aminophenyl) ethyleneglycol-N,N,N0,N0-tetraacetic acid tetraacetoxy-
methylester (BAPTA-AM) and N-2-hydroxyethylpiperazine-N 0-
2-ethanesulfonic acid (HEPES) were purchased from Dojindo
Laboratories (Kumamoto, Japan). Anti-human b1 integrin mouse
monoclonal antibody (mAb) (clone P5D2) was purchased from
Chemicon International, Inc. (Temecula, CA, USA). Isotypic controlblished by Elsevier B.V. All rights reserved.
6474 M. Gokoh et al. / FEBS Letters 579 (2005) 6473–6478mouse IgG1 was obtained from Immunotech (Marseille, France) and
FITC-conjugated goat anti-mouse IgG (H + L) was from Beckman
Coulter, Inc. (Fullerton, CA, USA).
2.2. Cells
Human promyelocytic leukemia HL-60 cells and human monocytic
leukemia U937 cells were grown at 37 C in RPMI 1640 medium (Asa-
hi Technoglass Co., Chiba, Japan) supplemented with 10% fetal bovine
serum (FBS) in an atmosphere of 95% air and 5% CO2. HL-60 cells
were diﬀerentiated into macrophage-like cells by treatment with
100 nM 1a, 25-(OH)2 vitamin D3 for 5 days. Human monocytes were
separated from the peripheral blood of young healthy donors as de-
scribed in [6]. Brieﬂy, a 1/4 volume of 6% Dextran T-500 (Amersham
Pharmacia Biotech, NJ, USA) in saline was added to heparinized
blood to sediment the erythrocytes. The supernatant was then centri-
fuged at 400 · g for 10 min. The sedimented cells were washed once
with Ca2+-, Mg2+-free Hanks balanced salt solution (HBSS) contain-
ing 5 mM HEPES (pH 7.4), transferred onto Lymphoprep (Axis
Shield, Oslo, Norway) and centrifuged at 800 · g for 20 min. The
mononuclear leukocyte fraction (the interface layer) was collected
and washed with HEPES–HBSS. Monocytes were separated from
other mononuclear leukocytes by negative selection using a MACS
monocyte isolation kit (Miltenyi Biotec Gmbh, Gladbach, Germany).
2.3. Adhesion assay
Adhesion of the cells was assayed using 96-well (ﬂat-bottom) poly-
styrene tissue culture plates (Becton–Dickinson, NJ, USA). Brieﬂy,
the wells were ﬁrst coated with BSA, ﬁbronectin or VCAM-1 (10 lg/
ml each) dissolved in 0.025 ml of Ca2+-, Mg2+-free phosphate buﬀered
saline (PBS) (pH 7.4) at room temperature for 1 h. Following the re-
moval of the protein solution, the wells were washed with PBS. The
wells were then blocked with BSA (10 mg/ml) in PBS for 30 min. 2-
AG was dissolved in dimethyl sulfoxide (DMSO), diluted with
0.05 ml of the medium (20 mM HEPES–RPMI 1640 medium supple-
mented with 2% FBS) (pH 7.4) and added to the well. Subsequently,
the cells (4 · 105) suspended in 0.05 ml of the medium were transferred
to the well (the ﬁnal concentration of DMSO in the well was 0.2%).
The incubation was carried out at 37 C for 5 min in an atmosphere
of 95% air and 5% CO2. The medium was then removed and the well
was washed twice with the medium. After the addition of 0.1 ml of
5 mMHEPES–HBSS containing 1 mM EDTA, the adherent cells were
resuspended by gentle pipetting. The number of cells was counted
using a hemocytometer.
2.4. Statistical analysis
The statistical analysis was performed using analysis of variance
(ANOVA) followed by Dunnetts test or Tukeys test. A P value
<0.05 was considered to be signiﬁcant.Time (min)
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3.1. Eﬀects of 2-AG and several cannabinoid receptor ligands
and their analogs on the adhesion of HL-60 cells
diﬀerentiated into macrophage-like cells to ﬁbronectin
First, we examined whether 2-AG aﬀects the adhesion of
HL-60 cells that have been diﬀerentiated into macrophage-like
cells. We found that treatment with 2-AG (1 lM) enhanced the
adhesion of the cells to the well coated with ﬁbronectin.
Fig. 1A shows the time course. The number of cells adhering
to the ﬁbronectin-coated well following stimulation with 2-
AG was apparently larger than that for the vehicle-treated
control throughout the incubation. The acceleration of cell
adhesion took place in a dose-dependent manner (Fig. 1B):
the eﬀect of 2-AG was detectable at 0.1 nM and increased up
to 1 lM.
The eﬀects of several cannabinoid receptor ligands and their
analogs on cell adhesion were examined next (Fig. 1C). The
addition of 2-AG (1 lM) enhanced the adhesion of the cells
to ﬁbronectin. In contrast to 2-AG, anandamide (1 lM) and
arachidonic acid (1 lM) did not aﬀect cell adhesion. On the
other hand, WIN55212-2 (1 lM), a cannabimimetic amin-
oalkylindole, exhibited appreciable activity comparable to that
of 2-AG, while WIN55212-3 (1 lM), an inactive isomer of
WIN55212-2, did not stimulate cell adhesion.3.2. Eﬀects of a CB2 receptor antagonist, PTX, and several
inhibitors of intracellular signaling on 2-AG-induced
enhanced adhesion to ﬁbronectin
We then examined whether the CB2 receptor is involved in
the stimulative eﬀect of 2-AG on cell adhesion. As demon-
strated in Fig. 2A, the addition of SR144528 (3 lM), a CB2
receptor-speciﬁc antagonist, abrogated the eﬀect of 2-AG. It
is apparent, therefore, that the 2-AG-induced enhanced adhe-
sion is mediated via the CB2 receptor. The eﬀect of pretreat-
ment of the cells with PTX was examined next. As shown in
Fig. 2B, the pretreatment abolished the stimulative eﬀect of
2-AG on cell adhesion, indicating that Gi/Go is crucially in-
volved. We also examined whether the intracellular free Ca2+
is involved in the enhanced adhesion. We found that the addi-G] (M)
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Fig. 2. Eﬀects of a CB2 receptor antagonist, PTX and BAPTA-AM on 2-AG-induced augmented adhesion of HL-60 cells diﬀerentiated into
macrophage-like cells to ﬁbronectin. (A) Cells (4 · 105) were incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) and
SR144528 (3 lM) at 37 C for 5 min. (B) Cells were pretreated with PTX (100 ng/ml) at 37 C for 16 h prior to the assay. Cells (4 · 105) were then
incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) at 37 C for 5 min. (C) Cells were pretreated with BAPTA-AM (20 lM)
for 30 min prior to the assay. Cells (4 · 105) were further incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) at 37 C for
5 min. Adhesion of the cells was determined as described in Section 2. The data are the means ± S.D. from four determinations. The statistical
analysis was performed using ANOVA followed by Tukeys test. \\\P < 0.001, N.S., not signiﬁcant.
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lar free Ca2+, markedly reduced 2-AG-induced augmented cell
adhesion (Fig. 2C). It is evident, therefore, that the intracellu-
lar free Ca2+ is essential for 2-AG to promote adhesion.
We next investigated the eﬀects of several inhibitors of intra-
cellular signal transduction on the enhanced adhesion of 2-
AG-treated cells to ﬁbronectin. As shown in Fig. 3, treatment
of the cells with wortmannin (a phosphatidylinositol 3-kinase
(PI3K) inhibitor, 200 nM) markedly suppressed 2-AG-induced
enhanced cell adhesion, suggesting that PI3K is involved in the
stimulative eﬀect of 2-AG. On the other hand, treatment of theA
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Fig. 3. Eﬀects of several inhibitors of intracellular signaling molecules
on 2-AG-induced augmented adhesion of HL-60 cells diﬀerentiated
into macrophage-like cells to ﬁbronectin. Cells were pretreated with
several inhibitors (20 lM for herbimycin A, PD98059 and Ro-31-8220
and 200 nM for wortmannin) at 37 C for 60 min. Cells (4 · 105) were
further incubated in 0.1 ml of the medium in the presence or absence of
2-AG (1 lM) at 37 C for 5 min. Adhesion of the cells was determined
as described in Section 2. The data are the means ± S.D. from four
determinations. The statistical analysis was performed using ANOVA
followed by Tukeys test. \P < 0.05, \\P < 0.01, N.S., not signiﬁcant.cells with herbimycin A (a tyrosine kinase inhibitor, 20 lM),
PD98059 (a p42/44 MAP kinase (MEK) inhibitor, 20 lM) or
Ro-31-8220 (a protein kinase C inhibitor, 20 lM) did not
remarkably aﬀect the enhanced adhesion induced by 2-AG.3.3. 2-AG-induced enhanced adhesion to ﬁbronectin is b integrin-
dependent
Fibronectin is a ligand for b1 integrin; we then examined
whether the stimulative eﬀect of 2-AG on cell adhesion is med-
iated by b1 integrin. In this experiment, we ﬁrst investigated
the adhesion of the cells to VCAM-1, another ligand for b1
integrin. As shown in Fig. 4A, 2-AG did not aﬀect the adhe-
sion of the cells to the well treated with BSA alone. On the
other hand, the addition of 2-AG enhanced the adhesion of
the cells to the VCAM-1-coated well as in the well coated with
ﬁbronectin.
We next examined the eﬀect of anti-b1 integrin mAb on the
enhanced adhesion to ﬁbronectin induced by 2-AG. As shown
in Fig. 4B, treatment of the cells with anti-b1 integrin mAb
(5 lg/ml) abrogated the eﬀect of 2-AG, indicating that b1 inte-
grin is involved in the stimulative eﬀect of 2-AG on cell adhe-
sion to ﬁbronectin.3.4. Eﬀects of 2-AG on the adhesion of human monocytic
leukemia U937 cells and human peripheral blood monocytes
to ﬁbronectin
Finally, we examined whether 2-AG aﬀects the adhesion of
cells other than diﬀerentiated HL-60 cells. In this experiment,
we examined the eﬀects of 2-AG on human monocytic leuke-
mia U937 cells and human peripheral blood monocytes. As
shown in Fig. 5A, the addition of 2-AG (1 lM) enhanced
the adhesion of U937 cells to ﬁbronectin. 2-AG also stimulated
the adhesion of human peripheral blood monocytes (Fig. 5B).
The enhanced adhesion of either U937 cells or human periph-
eral blood monocytes was abolished by treatment of the cells
with SR144528 (3 lM) (Fig. 5A and B), indicating that the
stimulation of cell adhesion was mediated via the CB2 receptor
as in the case of diﬀerentiated HL-60 cells.
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Fig. 4. Eﬀects of 2-AG on the adhesion of HL-60 cells diﬀerentiated into macrophage-like cells to ﬁbronectin and VCAM-1 and the eﬀect of anti-b1
integrin mAb on the adhesion of the cells to ﬁbronectin. The wells were ﬁrst coated with BSA, ﬁbronectin or VCAM-1 (10 lg/ml each) at room
temperature for 1 h. After the removal of the protein solution, the wells were blocked with BSA. (A) Cells (4 · 105) were incubated in 0.1 ml of the
medium in the presence or absence of 2-AG (1 lM) at 37 C for 5 min. (B) Cells were pretreated with control IgG or anti-b1 integrin mAb (5 lg/ml
each) for 15 min prior to the assay. Cells (4 · 105) were further incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) at 37 C
for 5 min in the well coated with ﬁbronectin. Adhesion of the cells was determined as described in Section 2. The data are the means ± S.D. from four
determinations. The statistical analysis was performed using ANOVA followed by Tukeys test. \\\P < 0.001, N.S., not signiﬁcant.
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Fig. 5. Eﬀects of 2-AG on the adhesion of human monocytic leukemia U937 cells and human peripheral blood monocytes to ﬁbronectin. (A) U937
cells (4 · 105) were incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) and SR144528 (3 lM) at 37 C for 5 min.
(B) Human peripheral blood monocytes (4 · 105) were incubated in 0.1 ml of the medium in the presence or absence of 2-AG (1 lM) and SR144528
(3 lM) at 37 C for 5 min. Adhesion of the cells was determined as described in Section 2. The data are the means ± S.D. from six (A) or ﬁve
(B) determinations. The statistical analysis was performed using ANOVA followed by Tukeys test. \\\P < 0.001, N.S., not signiﬁcant.
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The CB2 receptor is abundantly expressed in various lym-
phoid tissues such as the spleen and tonsils [13]. Several types
of leukocytes such as B lymphocytes [14], natural killer cells
[14,15], monocytes/macrophages [14], eosinophils [16], mast
cells [17] and dendritic cells [18] are known to express the
CB2 receptor. Notably, levels of the CB2 receptor in tissues
other than the lymphoid tissues are generally low [13]. It is ra-
tional, therefore, to assume that the CB2 receptor plays some
essential role during the course of inﬂammatory reactions and
immune responses.
Casellas and co-workers [19] reported the involvement of the
CB2 receptor in the modulation of chemokine production in
HL-60 cells and the diﬀerentiation of B lymphocytes [20].
We have focused on 2-AG and found that it induces the acti-
vation of p42/44 MAP kinase [5], augmented production ofchemokines in HL-60 cells [9] and the migration of HL-60 cells
that had been diﬀerentiated into macrophage-like cells [6], hu-
man peripheral blood monocytes [6], natural killer cells [15]
and eosinophils [16] through CB2 receptor-dependent mecha-
nisms. Several investigators have also reported that 2-AG in-
duces the migration of mouse splenocytes [7] and microglia
cells [8], modulates lymphocyte proliferation [11,12], sup-
presses the production of interleukin 6 (IL-6) in J774 macro-
phage-like cells [21] and attenuates tumor-necrosis factor-a
(TNF-a) production in lipopolysaccharide-stimulated mouse
macrophages [22], although, in some cases, it is not clear
whether the eﬀects of 2-AG are actually mediated via the
CB2 receptor. Recently, we obtained evidence that 2-AG in-
duces rapid actin polymerization in HL-60 cells [10] and ear
swelling in mice [23] in a CB2 receptor-dependent manner.
Zhao et al. [24] also demonstrated that 2-AG induces the acti-
vation of activator protein-1 (AP-1) in JB6 P+ cells. These
M. Gokoh et al. / FEBS Letters 579 (2005) 6473–6478 6477observations highlighted the possible involvement of the
CB2 receptor and its endogenous ligand 2-AG in the modula-
tion of several types of inﬂammatory reactions and immune
responses.
In this study, we examined the eﬀects of several cannabi-
noid receptor ligands on the adhesion of HL-60 cells diﬀeren-
tiated into macrophage-like cells. We found that 2-AG
augmented the adhesion of the cells to ﬁbronectin (Fig. 1).
A similar result was obtained for another cannabinoid recep-
tor ligand, WIN55212-2 (Fig. 1). To our knowledge, this is
the ﬁrst report that cannabinoid receptor ligands augment cell
adhesion.
It is apparent that the eﬀect on adhesion was mediated via
the CB2 receptor and Gi/Go, because treatment of the cells
with either SR144528 or PTX abolished the response
(Fig. 2). We also found that intracellular free Ca2+ is involved
in 2-AG-induced augmented adhesion of the cells to ﬁbronec-
tin (Fig. 2). Several investigators have already demonstrated
that intracellular Ca2+ is required for integrin-mediated cell
adhesion [25]. We have previously demonstrated that 2-AG
induces a rapid increase in the intracellular free Ca2+ concen-
tration in HL-60 cells [2]; inositol 1,4,5-trisphosphate recep-
tor-mediated Ca2+ release may play a part in the activation
of b1 integrin in 2-AG-stimulated cells as in anti-IgM anti-
body-stimulated lymphoma cells [26]. PI3K was also suggested
to be involved in the enhanced adhesion in 2-AG-treated cells
(Fig. 3). PI3K may be involved in the activation of b1 integrin
in 2-AG-stimulated cells, because PI3K has been shown to be
involved in the activation of integrins in several types of cells
[26,27]. The involvement of PI3K in cannabinoid receptor-
mediated cellular responses has already been reported by
several investigators [28,29]. Recently, we found that 2-AG
induces a rapid rearrangement of actin ﬁlaments via a PI3K-
dependent fashion [10]. It is also plausible, therefore, that 2-
AG induces a rapid rearrangement of actin ﬁlaments thereby
inducing robust adhesion of the cells to extracellular matrix
proteins and adhesion molecules.
Whatever the precise intracellular mechanism involved, the
ﬁnding that 2-AG enhanced the adhesion of the cells to ﬁbro-
nectin and VCAM-1 via an integrin-mediated process is partic-
ularly noteworthy. b1-Integrin-dependent cell adhesion is
indispensable for the extravasation of various inﬂammatory
cells and immune-competent cells and the inﬁltration of these
cells into tissues [27]. Recently, we obtained clear evidence that
2-AG is rapidly produced in 12-O-tetradecanoylphorbor-13-
acetate (TPA)-treated mouse ear and that 2-AG and the CB2
receptor play crucial stimulative roles during the course of
TPA-induced acute inﬂammation [23]. We also found the gen-
eration of 2-AG and the involvement of 2-AG and the CB2
receptor in contact dermatitis induced by topical application
of oxazolone to the ear of sensitized mice, which was accompa-
nied by edema and the inﬁltration of mononuclear leukocytes
into inﬂamed sites (Oka, S and Sugiura, T., unpublished re-
sults). The exact mechanism by which 2-AG and the CB2
receptor participate in acute inﬂammation and allergic reac-
tion is not yet fully elucidated. However, considering the
results of the present investigation, it seems conceivable that
2-AG and the CB2 receptor stimulate inﬂammatory reactions
and allergic responses at least in part by inducing robust adhe-
sion of inﬂammatory cells and immune-competent cells to
vascular endothelial cells, extracellular matrix proteins and
other inﬂammatory or immune-competent cells.Not much information is thus far available concerning the
physiological and pathophysiological roles of 2-AG in inﬂam-
mation and immunity despite the expression of its receptor,
i.e., the CB2 receptor, in several types of inﬂammatory cells
and immune-competent cells. Further detailed studies on 2-
AG and the CB2 receptor would shed light on the precise
regulatory mechanisms of various inﬂammatory reactions
and immune responses.References
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